ReachRxResearch
Home
Research
Sign Up
Changes in Characteristics Associated With ADHD and ASD Diagnoses Over Time
Back to Research Hub
  1. Home
  2. Research Hub
  3. Changes in Characteristics Associated Wi…

Changes in Characteristics Associated With ADHD and ASD Diagnoses Over Time

JAMA Psychiatry·September 9
PsychiatryPractice changingAttention-Deficit/Hyperactivity DisorderAutism Spectrum DisorderMatched Case-Control StudyAdolescentPediatric

Summary

View source

What was studied

This population-based matched case-control study used Danish nationwide registry data (births 1994–2022) to examine whether associations between 19 prediagnostic characteristics (socioeconomic, perinatal, health care use) and ADHD/ASD diagnoses changed from 2012 to 2022 in individuals followed to age 18.

Key findings

Among 71,317 cases (ADHD or ASD) matched to 713,170 controls, associations between known risk factors and diagnosis weakened significantly over time. For example, the OR for low birth weight fell from 1.54 (95% CI, 1.41–1.68) in 2012–2013 to 1.17 (95% CI, 1.10–1.24) in 2020–2022. Attenuation was stronger for ADHD than ASD (mean yearly OR change: 6.5% vs. 0.7% for household income) and more pronounced in those diagnosed at ages 10–17 than at younger ages.

Study limitations

- Registry-based design captures diagnoses as recorded in Danish health systems, which may not reflect true prevalence or diagnostic accuracy. - Findings are from Denmark and may not generalize to other health care systems with different diagnostic practices. - The study cannot distinguish between changes in diagnostic thresholds, clinician behavior, and genuine shifts in population risk.

Clinical implications

Rising ADHD and ASD diagnosis rates likely reflect broadening diagnostic practices or expanded health care capacity, not a true increase in underlying risk — but clinicians should not interpret this as evidence that these conditions are less impairing at the individual level. Children newly diagnosed, especially older adolescents, may have milder or less classically risk-burdened presentations than those diagnosed a decade ago.

Caveats

  • No drug exposures or therapeutic modalities are evaluated; modality and brand/generic tags are not applicable to this study.
  • Sample size tag reflects 71,317 cases + 713,170 controls (total n=784,487); the broader registry included 2,194,951 individuals but not all were cases or matched controls in the analytic sample.
  • The 'practice_changing' impact flag was applied because findings directly challenge common interpretations of rising ADHD/ASD rates, though the study is observational and limited to Denmark.

Related Questions

Explore related topics

How have ADHD diagnostic criteria and rates changed over the past decade in children and adolescents?What risk factors are most strongly associated with ASD diagnosis in pediatric populations?Does broadening of diagnostic thresholds for ADHD and ASD affect treatment outcomes or resource allocation?

Publication Details

Year
2026
Journal
JAMA Psychiatry
Sample Size
n=784,487
Source
View article
Keep scrolling
More content below.
Up Next